Can a simple antioxidant prevent post-procedure pancreatitis?
NCT ID NCT06252441
First seen Mar 30, 2026 · Last updated May 09, 2026 · Updated 6 times
Summary
This study tested whether taking N-Acetyl cysteine (NAC) by mouth is as good as or better than a standard rectal anti-inflammatory drug (diclofenac) for preventing pancreatitis after an ERCP, a procedure to examine the bile ducts. 46 adults at risk were enrolled. The main goal was to see who developed pancreatitis and to measure inflammation markers in the blood.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST-ERCP PANCREATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Obstructive Jaundice Clinic in the National Liver Institute, Menoufia University , Shebin Elkoom
Menofia, Egypt
Conditions
Explore the condition pages connected to this study.